1. Activity of a novel anthracenedione 1,4-dihydroxy-5,8-bis{{{2-[(2-hydroxyethyl)amino]ethyl}amino}}-9,10-anthracenedione dihydrochloride, against experimental tumours in mice;Wallace;Cancer Res,1979
2. Safety assessment of a new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin;Sparano;Cancer Treat Rep,1982
3. Phase II trial of mitoxantrone;Anderson;Cancer Treat Rep,1982
4. A phase II study of dihydroxyanthracenedione (DHAD) (NSC-301739) in metastatic breast cancer (abstract);Yap,1981
5. Mitoxantrone: a phase II study in the treatment of patients with advanced breast carcinoma and other solid tumours;Stuart-Harris;Cancer Chemother Pharmacol,1982